The mission of the NCI’s Office of Cancer Genomics (OCG) is to enhance understanding of the molecular mechanisms of cancer, with the ultimate goal of improving the prevention, early detection, diagnosis, and treatment of cancer. Learn More
The Initiative for Chemical Genetics (ICG)
The ICG provides a systematic approach to study biology using such small molecules, to develop new screening tools and compounds, and to accelerate the development of new cancer strategies and therapies....more
The Cancer Genome Atlas (TCGA)
TCGA is a collaborative effort between the NCI and the NHGRI that will test the feasibility of a large-scale systematic approach to identify genetic alterations in human cancer....more
Cancer Genetic Markers of Susceptibility (CGEMS)
CGEMS is an NCI enterprise initiative to conduct whole-genome association studies to identify genes giving rise to risk of prostate and breast cancer....more
Therapeutically Applicable Research to Generate
Effective Treatments (TARGET)
The TARGET Initiative seeks to harness the power of modern genomics technologies to rapidly identify valid therapeutic targets in childhood cancers so that new, more effective treatments can be developed....more
TARGET Study Finds Predictor of Relapse for Acute Lymphoblastic Leukemia
January 7, 2009
The Cancer Genome Atlas Reports First Results of Comprehensive Study of Brain Tumors
September 4, 2008
Click here to read past news.
For more information about funding available through the Office of Cancer Genomics, click here.